Subscribe to RSS
DOI: 10.1055/s-0038-1646701
Specific Inhibition of Platelet Agglutination and Aggregation by Aromatic Amidino Compounds
Publication History
Received 03 February 1977
Accepted 12 August 1977
Publication Date:
12 July 2018 (online)
Summary
A series of aromatic amidino compounds were investigated for their inhibitory effect on platelet agglutination and platelet aggregation. Agglutination of fresh or fixed platelets was produced by bovine plasma or by human plasma in combination with ristocetin, while aggregation of fresh platelets was induced by ADP, thrombin or collagen. Highly effective inhibitors were found for both types of platelet clumping, but there was no parallelism between the inhibitory activities in the two test systems. 5-(5-amidino-2-benzimidazolyl)-2-(4-hydroxyben-zene)benzimidazole suppressed agglutination exclusively. Pentamidine, on the other hand, strongly blocked the aggregation reactions, but did not interfere with agglutination, even at high concentrations. Compounds which inhibited aggregation also prevented the liberation of serotonin from the platelets.
-
References
- 1 Allain JP, Cooper HA, Wagner RH, Brinkhous KM. 1975; Platelets fixed with paraformaldehyde: A new reagent for assay of von Willebrand factor and platelet aggregating factor. Journal of Laboratory and Clinical Medicine 85: 318
- 2 Bottechia D, Vermylen J. 1976; Factor VIII and human platelet aggregation. I. Evidence that the platelet aggregating activity of bovine factor VIII is a property of its ‘carrier’ protein subunit. British Journal of Haematology 34: 303
- 3 Brinkhous KM. 1975; Hemophilia and von Willebrand’s disease. Some biological determinants. American Journal of Clinical Pathology 63: 609
- 4 Brinkhous KM, Graham JB, Cooper HA, Allain JP, Wagner RH. 1975; Assay of von Willebrand factor in von Willebrand’s disease and hemophilia: use of a macroscopic platelet aggregation test. Thrombosis Research 6: 267
- 5 Brinkhous KM, Leroy EC, Cornell WP, Brown RC, Hazlehurst JL, Vennart GP. 1958; Macroscopic studies of platelet agglutination; nature of thrombocyte agglutinating activity of plasma. Proceedings of the Society for Experimental Biology and Medicine 98: 379
- 6 Dann O, Bergen G, Demant E, Volz G. 1971; Trypanocide Diamidine des 2-Phenyl-indens und 2-Phenyl-indols. Justus Liebigs Annalen der Chemie 749: 68
- 7 Dann O, Fernbach R, Pfeifer W, Demant E, Bergen G, Lang S, Lürding G. 1972; Trypanocide Diamidine mit drei Ringen in zwei isolierten Ringsystemen. Justus Liebigs Annalen der Chemie 760: 37
- 8 Dann O, Hieke E, Hahn H, Miserre HH, Lürding G, Rössler R. 1970; Mehrkernige Thiophene, VIII. Trypanocide Diamidine des 2-Phenyl-thionaphthens. Justus Liebigs Annalen der Chemie 734: 23
- 9 Dann O, Volz G, Demant E, Pfeifer W, Bergen G, Fick H, Walkenhorst E. 1973 Trypanocide Diamidine mit vier Ringen in einem oder zwei Ringsystemen. Justus Liebigs Annalen der Chemie 1112
- 10 Dowling SV, Ekert H. 1976; A comparison of two methods for measurement of von Willebrand’s factor (ristocetin co-factor). Thrombosis and Haemostasis 36: 284
- 11 Forbes CD, Barr RD, Mcnicol GP, Douglas AS. 1972; Aggregation of human platelets by commercial preparations of bovine and porcine antihaemophilic globulin. Journal of Clinical Pathology 25: 210
- 12 Forbes CD, Prentice CRM. 1973; Aggregation of human platelets by purified porcine and bovine antihaemophilic factor. Nature New Biology 241: 149
- 13 Gangarosa EJ, Johnson TR, Ramos HS. 1960; Ristocetin-induced thrombocytopenia: site and mechanism of actions. Archives of Internal Medicine 105: 83
- 14 Glusa E, Barthel W, Markwardt F. 1974; The influence of benzamidine derivatives on human platelet function. Thrombosis et Diathesis Haemorrhagica 31: 172
- 15 Griggs TR, Cooper HA, Webster WP, Wagner RH, Brinkhous KM. 1973; Plasma aggregating factor (bovine) for human platelets: A marker for study of antihemophilic and von Willebrand factors. Proceedings of the National Academy of Sciences of The United States of America 70: 2814
- 16 Hauptmann J, Hoffmann J, Markwardt F. 1976; Zur Wirkung von aromatischen Bisamidinen auf Blutgerinnungs- und Fibrinolysevorgänge. Acta Biologica et Medica Germanica 35: 635
- 17 Holmberg L, Nilsson IM. 1972; Genetic variants of von Willebrand’s disease. British Medical Journal 3: 317
- 18 Holmsen H, Ostvold AC, Day HJ. 1973; Behaviour of endogenous and newly absorbed serotonin in the platelet release reaction. Biochemical Pharmacology 22: 2599
- 19 Hovig T. 1963; Aggregation of rabbit blood platelets produced in vitro by saline “extract” of tendons. Thrombosis et Diathesis Haemorrhagica 9: 248
- 20 Howard MA, Firkin BC. 1971; Ristocetin – a new tool in the investigation of platelet aggregation. Thrombosis et Diathesis Haemorrhagica 26: 362
- 21 Kirby EP. 1975; Evans Blue: A specific inhibitor of factor VIII-induced platelet agglutination. Thrombosis et Diathesis Haemorrhagica 34: 770
- 22 Kirby EP, Mills DCB. 1975; The interaction of bovine factor VIII with human platelets. Journal of Clinical Investigation 56: 491
- 23 Macfarlane RG, Biggs R, Bidwell E. 1954; Bovine antihaemophilic globulin in the treatment of haemophilia. Lancet 1: 1316
- 24 Mohammad SF, Mason RG. 1974; Inhibition of human platelet-collagen adhesion reaction by amitriptyline and imipramine. Proceedings of the Society for Experimental Biology and Medicine 145: 1106
- 25 Mohammad SF, Reddick RL, Mason RG. 1975; Characterization of human platelets separated from blood by ADP-induced aggregation. American Journal of Pathology 79: 81
- 26 Mustard JF, Packham MA, Perry DW, Guccione MA, Kinlough-Rathbone RL. 1975. Enzyme activities on the platelet surface in relation to the action of adenosine diphosphate. In: Biochemistry and Pharmacology of Platelets. Ciba Foundation Symposium 35 Elsevier-Excerpta Medica-North Holland; Amsterdam, Oxford, New York: p 47
- 27 Rennert O, Buehler B, Miale T, Lawson D. 1976; Polyamines and platelet aggregation. Life Sciences 79: 257
- 28 Saba SR, Mason RG. 1974; Studies of an activity from endothelial cells that inhibits platelet aggregation, serotonin release, and clot retraction. Thrombosis Research 5: 747
- 29 Solum NO. 1968; Aggregation of human platelets by bovine platelet fibrinogen. Scandinavian Journal of Haematology 5: 474
- 30 Tidwell RR, Fox LL, Geratz JD. 1976; Aromatic tris-amidines. A new class of highly active inhibitors of trypsin-like proteases. Biochimica et biophysica acta 445: 729
- 31 Vermylen J, De Gaetano G, Donati MB, Verstraete M. 1974; Platelet-aggregating activity in neuraminidase-treated human cryoprecipitates: its correlation with factor VIII-related antigen. British Journal of Haematology 26: 645
- 32 Vermylen J, Bottechia D, Szpilman H. 1976; Factor VIII and human platelet aggregation. III. Further studies on aggregation of human platelets by neuraminidase-treated human factor VIII. British Journal of Haematology 34: 321
- 33 Weissmann G, Davies P, Krakauer K, Hirschhorn R. 1970; Studies on lysosomes. XIII. Effects of stilbamidine and hydroxystilbamidine on in vitro and in vivo systems. Biochemical Pharmacology 79: 1251